Intravenous Therapy Solutions Global Market Report 2025
상품코드:1810929
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
정맥내 치료 솔루션 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 CAGR 10.1%로 성장할 전망이며, 193억 3,000만 달러로 성장이 예측됩니다. 예측 기간의 성장 원동력은 노인 인구 확대, 재택 보건 서비스 확대, 급속 보수 요법 수요 증가, 위장질환 유병률 상승, 단회 사용 점적용 컴포넌트의 사용 확대로 예상됩니다. 주요 동향은 점적 약물 전달 시스템의 발전, 재택 점적 치료로의 전환, 스마트 주입 펌프의 통합, 생물학적 제제 및 특수 약물의 점적 증가, 개별화된 점적 영양 치료에 대한 선호도 증가 등을 포함합니다.
저침습 치료에 대한 수요 증가는 정맥내 치료 솔루션 시장의 성장을 이끌 것으로 예측됩니다. 저침습 치료에서는 절개나 신체 진입을 최소한으로 억제한 치료가 이루어지기 때문에 회복이 빠르고 합병증이 적은 경우가 많습니다. 이러한 선호도 증가는 치료가 수술 후 통증을 줄이고 회복을 가속화하며 치유 중 환자의 편안함을 높일 수 있기 때문입니다. 정맥내 치료 솔루션은 체액, 약물 및 영양소를 혈류로 직접 전달하여 이러한 치료를 촉진하고 효과적인 환자 관리 및 회복을 촉진합니다. 예를 들어, 2024년 6월 미국 성형외과학회는 2023년 저침습 수술이 7% 증가했고, 수술의 성장률을 2% 초과했다고 보고했습니다. 따라서 저침습 치료에 대한 수요 증가는 정맥내 치료 솔루션 시장 확대에 박차를 가하고 있습니다.
정맥내 치료 솔루션 시장의 주요 기업은 치료 효율성을 높이고 임상 환경에서 준비 시간을 단축하기 위해 즉시 사용할 수 있는 약물 주입과 같은 혁신적인 제품에 주력하고 있습니다. Ready-to-use 주입은 미리 혼합되어 라벨이 붙은 점적약을 표준 용량으로 포장한 것으로, 현장에서의 희석이나 조제의 수고를 생략할 수 있습니다. 2024년 5월 미국 제조업체인 B. Braun Medical Inc.는 발작 치료용으로 설계된 즉시 사용할 수 있는 항경련제의 정주액인 레베틸라세탐 염화나트륨 주사액을 출시했습니다. 이 제품은 표준화된 농도와 용량으로 제공되므로 포인트 오브 케어에서 희석 또는 배합이 필요하지 않습니다. 이 제형은 유연한 용기에 미리 혼합되어 복용량의 정확성을 보장하고 오염 위험을 줄이며 응급 및 입원 환경에서 헬스케어 제공업체의 편의성을 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 정맥내 치료 솔루션 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 정맥내 치료 솔루션 시장 : 성장률 분석
세계의 정맥내 치료 솔루션 시장 실적 : 규모 및 성장(2019-2024년)
세계의 정맥내 치료 솔루션 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 정맥내 치료 솔루션 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 정맥내 치료 솔루션 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
결정질
콜로이드
혈액 제품
기타 제품 유형
세계의 정맥내 치료 솔루션 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
체액 및 전해질의 불균형
영양 지원
투약 관리
수혈
기타 용도
세계의 정맥내 치료 솔루션 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
외래수술센터(ASC)
재택 케어 환경
기타 최종 사용자
세계의 정맥내 치료 솔루션 시장 : 결정질 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
생리 식염수(0.9% 염화나트륨)
반생리 식염수(0.45% 염화나트륨)
젖산 링거액
덱스트로스 용액
고장 식염수
세계의 정맥내 치료 솔루션 시장 : 콜로이드 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
알부민
덱스트란
히드록시에틸 전분(HES)
젤라틴
세계의 정맥내 치료 솔루션 시장 : 혈액 제품 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
적혈구 농축액(PRBC)
혈소판
신선동결혈장(FFP)
클리오 프리시피테이트
세계의 정맥내 치료 솔루션 시장 : 기타 제품 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
정맥내 면역글로불린(IVIG)
비경구 영양 솔루션
특수 정맥내 약제 및 첨가제
제7장 지역별 및 국가별 분석
세계의 정맥내 치료 솔루션 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 정맥내 치료 솔루션 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
정맥내 치료 솔루션 시장 : 경쟁 구도
정맥내 치료 솔루션 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
Otsuka Pharmaceutical Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Baxter International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius Kabi AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Grifols SA
Terumo Corporation
Dr. Reddy's Laboratories Limited
Sichuan Kelun Pharmaceutical Co. Ltd.
Teleflex Incorporated
Hikma Pharmaceuticals PLC
ICU Medical Inc.
Biocon Limited
B. Braun Melsungen Aktiengesellschaft
JW Life Science Corporation
AdvaCare Pharma USA
Soxa Formulations & Research Pvt. Ltd.
Vifor Pharma Management Ltd.
Aetos Pharma Private Limited
LXIR Medilabs Private Limited
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
정맥내 치료 솔루션 시장(2029년) : 새로운 기회를 제공하는 국가
정맥내 치료 솔루션 시장(2029년) : 새로운 기회를 제공하는 부문
정맥내 치료 솔루션 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Intravenous therapy solutions are sterile liquid formulations administered directly into the bloodstream to deliver fluids, medications, nutrients, or electrolytes. These solutions are used to treat conditions such as dehydration, electrolyte imbalances, infections, and to provide essential nutrients when oral intake is not feasible. Typically composed of water, salts, sugars, or medicinal ingredients, they are customized based on individual patient requirements and specific medical conditions.
The primary types of intravenous therapy solutions include crystalloids, colloids, blood products, and others. Crystalloids consist of water mixed with electrolytes and are commonly used for rapid rehydration and fluid balance restoration in urgent medical situations. These solutions serve multiple purposes, including correcting fluid and electrolyte imbalances, supporting nutrition, administering medications, and enabling blood transfusions. They are utilized across a range of healthcare settings, including hospitals, clinics, ambulatory surgical centers, home care environments, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The intravenous therapy solutions market research report is one of a series of new reports from The Business Research Company that provides intravenous therapy solutions market statistics, including the intravenous therapy solutions industry global market size, regional shares, competitors with the intravenous therapy solutions market share, detailed intravenous therapy solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the intravenous therapy solutions industry. These intravenous therapy solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The intravenous therapy solutions market size has grown rapidly in recent years. It will grow from $11.95 billion in 2024 to $13.17 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. Growth during the historic period was driven by rising hospital admissions, an increase in surgical procedures, a growing incidence of dehydration, higher rates of chronic diseases, and enhanced access to healthcare infrastructure.
The intravenous therapy solutions market size is expected to see rapid growth in the next few years. It will grow to $19.33 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. Growth in the forecast period is expected to be driven by the expanding elderly population, growth in home healthcare services, increased demand for rapid rehydration therapies, a rising prevalence of gastrointestinal disorders, and greater use of single-use IV components. Key trends include advancements in intravenous drug delivery systems, a move toward home-based IV therapy, the integration of smart infusion pumps, growth in biologic and specialty drug infusions, and a growing preference for personalized IV nutrition treatments.
The increasing demand for minimally invasive therapies is expected to drive growth in the intravenous therapy solutions market. Minimally invasive therapies involve medical treatments with minimal incisions or bodily entry, often resulting in quicker recovery and fewer complications. This rising preference is attributed to the therapies' ability to reduce postoperative pain, leading to faster recovery and greater patient comfort during healing. Intravenous therapy solutions facilitate these treatments by delivering fluids, medications, and nutrients directly into the bloodstream, promoting effective patient care and accelerated recovery. For example, in June 2024, the American Society of Plastic Surgeons reported that minimally invasive procedures increased by 7% in 2023, surpassing the growth rate of surgical procedures by 2%. Hence, the rising demand for minimally invasive therapies is fueling the expansion of the intravenous therapy solutions market.
Key players in the intravenous therapy solutions market are focusing on innovative products such as ready-to-use drug infusions to improve treatment efficiency and reduce preparation time in clinical environments. Ready-to-use drug infusions consist of pre-mixed and pre-labeled intravenous medications packaged in standardized doses, eliminating the need for on-site dilution or compounding. In May 2024, B. Braun Medical Inc., a US-based manufacturer, introduced Levetiracetam in Sodium Chloride Injection, a ready-to-use intravenous anticonvulsant solution designed for seizure treatment. This product comes in standardized concentrations and volumes, removing the requirement for dilution or compounding at the point of care. The formulation is pre-mixed in a flexible container to ensure dosing accuracy, reduce contamination risks, and improve convenience for healthcare providers in emergency and inpatient settings.
In April 2025, Organon & Co., a US-based healthcare company, acquired the regulatory and commercial rights to Tofidence from Biogen Inc. This acquisition aims to strengthen and expand Organon & Co.'s biosimilars immunology portfolio in the US by including Tofidence to support treatments for multiple arthritis conditions and COVID-19. The company plans to leverage its commercial expertise and market access capabilities to foster long-term growth in the immunology sector. Biogen Inc. is a US-based biotechnology firm specializing in intravenous therapy solutions like Tofidence.
Major players in the intravenous therapy solutions market are Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Teleflex Incorporated, Hikma Pharmaceuticals PLC, ICU Medical Inc., Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited.
North America was the largest region in the intravenous therapy solutions market in 2024. The regions covered in intravenous therapy solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the intravenous therapy solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The intravenous therapy solutions market consists of sales of saline solutions, dextrose solutions, lactated Ringer's solutions, amino acid solutions, vitamin and mineral infusions, IV antibiotic solutions, chemotherapy IV solutions, and parenteral nutrition solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intravenous Therapy Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on intravenous therapy solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for intravenous therapy solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous therapy solutions market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Crystalloids; Colloids; Blood Products; Other Product Types
2) By Application: Fluid And Electrolyte Imbalance; Nutritional Support; Medication Administration; Blood Transfusion; Other Applications
3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Home Care Settings; Other End-Users
Subsegments:
1) By Crystalloids: Normal Saline (0.9% Sodium Chloride); Half Normal Saline (0.45% Sodium Chloride); Lactated Ringer's Solution; Dextrose Solutions; Hypertonic Saline
2) By Colloids: Albumin; Dextran; Hydroxyethyl Starch (HES); Gelatin
3) By Blood Products: Packed Red Blood Cells (PRBCs); Platelets; Fresh Frozen Plasma (FFP); Cryoprecipitate
4) By Other Product: Intravenous Immunoglobulins (IVIG); Parenteral Nutrition Solutions; Specialty Intravenous Drugs And Additives
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Otsuka Pharmaceutical Co. Ltd.; Baxter International Inc.; Fresenius Kabi AG; Grifols S.A.; Terumo Corporation; Dr. Reddy's Laboratories Limited; Sichuan Kelun Pharmaceutical Co. Ltd.; Teleflex Incorporated; Hikma Pharmaceuticals PLC; ICU Medical Inc.; Biocon Limited; B. Braun Melsungen Aktiengesellschaft; JW Life Science Corporation; AdvaCare Pharma USA; Soxa Formulations & Research Pvt. Ltd.; Vifor Pharma Management Ltd.; Aetos Pharma Private Limited; LXIR Medilabs Private Limited
3. Intravenous Therapy Solutions Market Trends And Strategies
4. Intravenous Therapy Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Intravenous Therapy Solutions Growth Analysis And Strategic Analysis Framework
5.1. Global Intravenous Therapy Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Intravenous Therapy Solutions Market Growth Rate Analysis
5.4. Global Intravenous Therapy Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Intravenous Therapy Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Intravenous Therapy Solutions Total Addressable Market (TAM)
6.1. Global Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Crystalloids
Colloids
Blood Products
Other Product Types
6.2. Global Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluid And Electrolyte Imbalance
Nutritional Support
Medication Administration
Blood Transfusion
Other Applications
6.3. Global Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Other End-Users
6.4. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Normal Saline (0.9% Sodium Chloride)
Half Normal Saline (0.45% Sodium Chloride)
Lactated Ringer's Solution
Dextrose Solutions
Hypertonic Saline
6.5. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Albumin
Dextran
Hydroxyethyl Starch (HES)
Gelatin
6.6. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Blood Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Packed Red Blood Cells (PRBCs)
Platelets
Fresh Frozen Plasma (FFP)
Cryoprecipitate
6.7. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Immunoglobulins (IVIG)
Parenteral Nutrition Solutions
Specialty Intravenous Drugs And Additives
7. Intravenous Therapy Solutions Market Regional And Country Analysis
7.1. Global Intravenous Therapy Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Intravenous Therapy Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Intravenous Therapy Solutions Market
9.1. China Intravenous Therapy Solutions Market Overview
9.2. China Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Intravenous Therapy Solutions Market
10.1. India Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Intravenous Therapy Solutions Market
11.1. Japan Intravenous Therapy Solutions Market Overview
11.2. Japan Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Intravenous Therapy Solutions Market
12.1. Australia Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Intravenous Therapy Solutions Market
13.1. Indonesia Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Intravenous Therapy Solutions Market
14.1. South Korea Intravenous Therapy Solutions Market Overview
14.2. South Korea Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Intravenous Therapy Solutions Market
15.1. Western Europe Intravenous Therapy Solutions Market Overview
15.2. Western Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Intravenous Therapy Solutions Market
16.1. UK Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Intravenous Therapy Solutions Market
17.1. Germany Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Intravenous Therapy Solutions Market
18.1. France Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Intravenous Therapy Solutions Market
19.1. Italy Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Intravenous Therapy Solutions Market
20.1. Spain Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Intravenous Therapy Solutions Market
21.1. Eastern Europe Intravenous Therapy Solutions Market Overview
21.2. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Intravenous Therapy Solutions Market
22.1. Russia Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Intravenous Therapy Solutions Market
23.1. North America Intravenous Therapy Solutions Market Overview
23.2. North America Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Intravenous Therapy Solutions Market
24.1. USA Intravenous Therapy Solutions Market Overview
24.2. USA Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
